A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck

BACKGROUND: Induction chemotherapy (IC) in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN) often compromises compliance with subsequent chemoradiotherapy (CRT), which negatively affects outcomes. Here, we assessed the combination of paclitaxel (PTX), carboplatin (CBDCA), and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Enokida, Tomohiro, Ogawa, Takenori, Homma, Akihiro, Okami, Kenji, Minami, Shujiro, Nakanome, Ayako, Shimizu, Yasushi, Maki, Daisuke, Ueda, Yuri, Fujisawa, Takao, Motegi, Atsushi, Ohkoshi, Akira, Taguchi, Jun, Ebisumoto, Koji, Nomura, Shogo, Okano, Susumu, Tahara, Makoto
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7050099/
https://ncbi.nlm.nih.gov/pubmed/31943834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2852
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados